ACL Injury

1
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Arthrex
ArthrexCA - Santa Barbara
2 programs
1
OOCPhase 31 trial
Arthrex FastThread Interference ScrewN/A1 trial
Active Trials
NCT04689061UnknownEst. Aug 2023
NCT04993339CompletedEst. Feb 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
ArthrexOOC
ArthrexArthrex FastThread Interference Screw

Clinical Trials (2)

Clinical Outcomes of ACL Reconstruction Augmented by an Injectable Osteoconductive/Osteoinductive Compound

Start: Oct 2016Est. completion: Feb 2020
Phase 3Completed
NCT04689061ArthrexArthrex FastThread Interference Screw

FastThread Interference Screws

Start: Aug 2020Est. completion: Aug 2023
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
1 companies competing in this space